Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-06

Clinical Trial Update: Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1b/2a study of ABI-H0731 in patients with chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABI-H0731

Snippet

Sponsor: Assembly Biosciences | Conditions: Chronic Hepatitis B | Phase 1, Phase 2 | Status: COMPLETED